Novel Nanostructured Solid Materials for Modulating Oral Drug Delivery from Solid-State Lipid-Based Drug Delivery Systems.
Lipid-based drug delivery systems (LBDDS) have gained significant attention in recent times, owing to their ability to overcome the challenges limiting the oral delivery of poorly water-soluble drugs. Despite the successful commercialization of several LBDDS products over the years, a large discrepancy exists between the number of poorly water-soluble drugs displaying suboptimal in vivo performances and the application of LBDDS to mitigate their various delivery challenges. Conventional LBDDS, including lipid solutions and suspensions, emulsions, and self-emulsifying formulations, suffer from various drawbacks limiting their widespread use and commercialization. Accordingly, solid-state LBDDS, fabricated by adsorbing LBDDS onto a chemically inert solid carrier material, have attracted substantial interest as a viable means of stabilizing LBDDS whilst eliminating some of the various limitations. This review describes the impact of solid carrier choice on LBDDS performance and highlights the importance of appropriate solid carrier material selection when designing hybrid solid-state LBDDS. Specifically, emphasis is placed on discussing the ability of the specific solid carrier to modulate drug release, control lipase action and lipid digestion, and enhance biopharmaceutical performance above the original liquid-state LBDDS. To encourage the interested reader to consider their solid carrier choice on a higher level, various novel materials with the potential for future use as solid carriers for LBDDS are described. This review is highly significant in guiding future research directions in the solid-state LBDDS field and fostering the translation of these delivery systems to the pharmaceutical marketplace.
School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, 5001, Australia.
Tahnee J
TJ
Dening
School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, 5001, Australia.
Shasha
S
Rao
School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, 5001, Australia.
Nicky
N
Thomas
School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, 5001, Australia. clive.prestidge@unisa.edu.au.
Clive A
CA
Prestidge
D000284:Administration, Oral; D002626:Chemistry, Pharmaceutical; D004337:Drug Carriers; D016503:Drug Delivery Systems; D004655:Emulsions; D005079:Excipients / Q000737:chemistry*; D006801:Humans; D008055:Lipids / Q000737:chemistry*; D049329:Nanostructures / Q000737:chemistry*; D013535:Suspensions
D004337:Drug Carriers; D004655:Emulsions; D005079:Excipients; D008055:Lipids; D013535:Suspensions
lipid-based drug delivery systems; oral bioavailability; poorly water-soluble drugs; solid carriers; solid dosage forms